AffyImmune Therapeutics

About:

AffyImmune Therapeutics is a biopharmaceutical company developing genetically engineered immune cells to fight cancer.

Website: https://affyimmune.com/

Top Investors: ORI Capital

Description:

AffyImmune Therapeutics is a biopharmaceutical company specializing in affinity tuned Chimeric Antigen Receptor (“CAR”) T cell therapy in solid tumors. The Company’s proprietary technology may significantly improve the existing CAR-T cell therapy by extending the target of CAR-T therapies to solid tumors using a novel molecule and tuning down the affinity from picomolar to micromolar level to lower the on-target off-tumor toxicity.